[1] Lassen JF,Holm NR,Banning A,et al.Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club[J]. EuroIntervention, 2016, 12(1): 38-46. [2] 丁立成,王继群,石磊,等. 冠状动脉分叉病变介入治疗策略及技术[J]. 中国老年学杂志, 2016 [3] 张峻,张冬,赵志勇,等. 冠状动脉分叉病变介入治疗中小分支闭塞的发生率,预测因素及对围术期心肌梗死的影响[J]. 中国循环杂志, 2015, (10): 941-945. [4] 宋林林,金哲. 冠状动脉分叉病变介入治疗的边支保护和补救技术策略[J]. 中国介入心脏病学杂志, 2016, (12): 700-702. [5] 温尚煜,于宏颖,孙志奇,等. 经皮高速旋磨治疗冠状动脉钙化分叉病变:单中心经验[J]. 中国介入心脏病学杂志, 2014, (2): 102-105. [6] Mori H,Torii S,Kutyna M,et al. Coronary Artery Calcification and its Progression: What Does it Really Mean?[J]. JACC Cardiovasc Imaging, 2018, 11(1): 127-142. [7] Kim MC,Ahn Y,Sim DS,et al. Impact of calcified bifurcation lesions in patients undergoing percutaneous coronary intervention using drug-eluting stents: results from the COronary BIfurcation Stent (COBIS) II registry[J]. EuroIntervention, 2017, 13(3): 338-344. [8] Genereux P,Kumsars I,Lesiak M,et al.A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions[J]. J Am Coll Cardiol, 2015, 65(6): 533-543. [9] Movahed MR.Major limitations of randomized clinical trials involving coronary artery bifurcation interventions: time for redesigning clinical trials by involving only true bifurcation lesions and using appropriate bifurcation classification[J]. J Interv Cardiol, 2011, 24(4): 295-301. [10] Allali A,Abdel-Wahab M,Traboulsi H,et al.Impact of Lesion Preparation Technique on Side Branch Compromise in Calcified Coronary Bifurcations: A Subgroup Analysis of the PREPARE-CALC Trial[J]. J Interv Cardiol, 2020, 2020: 9740938-9740938. [11] Sharma SK,Tomey MI,Teirstein PS,et al. North American Expert Review of Rotational Atherectomy[J]. Circ Cardiovasc Interv, 2019, 12(5): 7448-7448. [12] Tomey MI,Kini AS,Sharma SK.Current status of rotational atherectomy[J]. JACC Cardiovasc Interv, 2014, 7(4): 345-353. [13] Ito H,Piel S,Das P,et al.Long-term outcomes of plaque debulking with rotational atherectomy in side-branch ostial lesions to treat bifurcation coronary disease[J]. J Invasive Cardiol, 2009, 21(11): 598-601. |